A Randomised, Double-Blind, Multiple Dose-Ascending, Placebo-Controlled Study in Healthy Volunteers and Parkinson's Disease Patients to Assess the Safety, Tolerability and PK of Daily Oral Administration of Cogane Over One Month
Latest Information Update: 15 Jan 2010
At a glance
- Drugs Sarsasapogenin (Primary)
- Indications Alzheimer's disease; Parkinson's disease
- Focus Adverse reactions
- Sponsors Phytopharm
- 21 Aug 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 14 Apr 2009 New trial record